Kelsie L Thu

10PUBLICATIONS
23CO-AUTHORS
Computer aided designPredictive and prognostic markersMolecular targetsCancer cell biologyMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 12, 2026
Pervasive Cas9 expression driven by mammalian promoter activity in E. coli affects representation of CRISPR sgRNA libraries.

|Apr 20, 2026
CD47 promotes mitogen-activated protein kinase and epithelial-to-mesenchymal transition molecular programs to drive prometastatic phenotypes in non-small cell lung cancer.

|Mar 28, 2026
Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer.

Kelsie L Thu, Soode Jafari, Jennifer Silvester

|Oct 29, 2025
Artemis (DCLRE1C) Acts as a Target to Enhance Radiotherapy Response in Triple-Negative Breast Cancer.

Vasudeva Bhat, Kelsie L Thu, Anayra de Fatima Goncalves Santiago

|Feb 26, 2025
Targeting Kinesins for Therapeutic Exploitation of Chromosomal Instability in Lung Cancer.

Christopher Zhang, Benson Z Wu, Kelsie L Thu

|Sep 28, 2024
Alternative Strategies for Delivering Immunotherapeutics Targeting the PD-1/PD-L1 Immune Checkpoint in Cancer.

Ryunosuke Hoshi, Kristyna A Gorospe, Hagar I Labouta

Pageof 2

Frequent Collaborators

4 joint publications

David W Cescon

2 joint publications

Warren L Lee

2 joint publications

Tak W Mak

1 joint publications

Isabel Soria-Bretones